Catherine M Phillips1, Ivan J Perry2. 1. HRB Centre for Diet and Health Research, Dept. of Epidemiology and Public Health, University College Cork, Cork, Ireland. Electronic address: c.phillips@ucc.ie. 2. HRB Centre for Diet and Health Research, Dept. of Epidemiology and Public Health, University College Cork, Cork, Ireland.
Abstract
OBJECTIVES: No data regards lipoprotein particle profiles in obese and non-obese metabolic health subtypes exist. We characterised lipoprotein size, particle and subclass concentrations among metabolically healthy and unhealthy obese and non-obese adults. METHODS: Cross-sectional sample of 1834 middle-aged Irish adults were classified as obese (BMI ≥30 kg/m(2)) and non-obese (BMI <30 kg/m(2)). Metabolic health was defined using three metabolic health definitions based on various cardiometabolic abnormalities including metabolic syndrome criteria, insulin resistance and inflammation. Lipoprotein size, particle and subclass concentrations were determined using nuclear magnetic resonance (NMR) spectroscopy. RESULTS: Lipoprotein profiling identified a range of adverse phenotypes among the metabolically unhealthy individuals, regardless of BMI and metabolic health definition, including increased numbers of small low density lipoprotein (LDL) (P < 0.001) and high density lipoprotein (HDL) particles (P < 0.001), large very low density lipoprotein (VLDL) particles (P < 0.001) and greater lipoprotein related insulin resistance (P < 0.001). The most significant predictors of metabolic health were lower numbers of large VLDL (ORs 2.72-3.13 and 2.49-3.86, P < 0.05 among obese and non-obese individuals, respectively) and small dense LDL particles (ORs 1.78-2.39 and 1.50-1.94, P < 0.05) and higher numbers of large LDL (ORs 1.82-2.66 and 2.84-3.27, P < 0.05) and large HDL particles (ORs 1.88-2.58 and 1.81-3.49, P < 0.05). CONCLUSIONS: Metabolically healthy adults displayed favourable lipoprotein particle profiles, irrespective of BMI and metabolic health definition. These findings underscore the importance of maintaining a healthy lipid profile in the context of overall cardiometabolic health.
OBJECTIVES: No data regards lipoprotein particle profiles in obese and non-obese metabolic health subtypes exist. We characterised lipoprotein size, particle and subclass concentrations among metabolically healthy and unhealthy obese and non-obese adults. METHODS: Cross-sectional sample of 1834 middle-aged Irish adults were classified as obese (BMI ≥30 kg/m(2)) and non-obese (BMI <30 kg/m(2)). Metabolic health was defined using three metabolic health definitions based on various cardiometabolic abnormalities including metabolic syndrome criteria, insulin resistance and inflammation. Lipoprotein size, particle and subclass concentrations were determined using nuclear magnetic resonance (NMR) spectroscopy. RESULTS: Lipoprotein profiling identified a range of adverse phenotypes among the metabolically unhealthy individuals, regardless of BMI and metabolic health definition, including increased numbers of small low density lipoprotein (LDL) (P < 0.001) and high density lipoprotein (HDL) particles (P < 0.001), large very low density lipoprotein (VLDL) particles (P < 0.001) and greater lipoprotein related insulin resistance (P < 0.001). The most significant predictors of metabolic health were lower numbers of large VLDL (ORs 2.72-3.13 and 2.49-3.86, P < 0.05 among obese and non-obese individuals, respectively) and small dense LDL particles (ORs 1.78-2.39 and 1.50-1.94, P < 0.05) and higher numbers of large LDL (ORs 1.82-2.66 and 2.84-3.27, P < 0.05) and large HDL particles (ORs 1.88-2.58 and 1.81-3.49, P < 0.05). CONCLUSIONS: Metabolically healthy adults displayed favourable lipoprotein particle profiles, irrespective of BMI and metabolic health definition. These findings underscore the importance of maintaining a healthy lipid profile in the context of overall cardiometabolic health.
Authors: Bárbara Fernández-Cidón; Ariadna Padró-Miquel; Pedro Alía-Ramos; María José Castro-Castro; Marta Fanlo-Maresma; Dolors Dot-Bach; José Valero-Politi; Xavier Pintó-Sala; Beatriz Candás-Estébanez Journal: Vasc Health Risk Manag Date: 2017-06-06
Authors: Alyson Ross; Robert Shamburek; Leslie Wehrlen; Stephen D Klagholz; Li Yang; Elyssa Stoops; Sharon L Flynn; Alan T Remaley; Karel Pacak; Nonniekaye Shelburne; Margaret F Bevans Journal: PLoS One Date: 2017-05-04 Impact factor: 3.240
Authors: Enrique Rodriguez-Garcia; Josefina Ruiz-Nava; Sonia Santamaria-Fernandez; Jose Carlos Fernandez-Garcia; Antonio Vargas-Candela; Raquel Yahyaoui; Francisco J Tinahones; Maria Rosa Bernal-Lopez; Ricardo Gomez-Huelgas Journal: Medicine (Baltimore) Date: 2017-07 Impact factor: 1.889
Authors: Doris M Jacobs; Lotte Smolders; Yuguang Lin; Niels de Roo; Elke A Trautwein; John van Duynhoven; Ronald P Mensink; Jogchum Plat; Velitchka V Mihaleva Journal: Front Mol Biosci Date: 2017-08-24